Developmental Disability

Vilitra 20 mg contains vardenafil, a phosphodiesterase type 5 (PDE5) inhibitor prescribed for the treatment of erectile dysfunction (ED). Vardenafil is also marketed under the brand Levitra. It works by enhancing nitric oxide–mediated vasodilation, improving blood flow to the penile tissues during sexual stimulation and supporting a firm, sustained erection.

The recommended starting dose is 20 mg taken approximately 30–60 minutes before sexual activity. Its onset of action is typically within one hour, with effects lasting up to 4–6 hours.

Common side effects may include headache, flushing, nasal congestion, and dizziness. Vilitra 20 mg should be used under medical supervision, particularly in patients with cardiovascular conditions or those taking nitrates, to ensure safe and effective treatment outcomes.